Evotec (OTCMKTS:EVTCY) Stock Passes Above 50 Day Moving Average – Should You Sell?

Evotec SE (OTCMKTS:EVTCY)’s stock price crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $3.29 and traded as high as $3.78. Evotec shares last traded at $3.78, with a volume of 103,260 shares trading hands.

Evotec Stock Down 0.3%

The company’s 50 day moving average is $3.29 and its 200 day moving average is $3.57. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The company has a market cap of $1.25 billion, a PE ratio of 9.22 and a beta of 0.98.

About Evotec

Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.

The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.